Terms: = Cervical cancer AND CCNE1, CCNE, 898, ENSG00000105173, P24864 AND Prognosis
7 results:
1. LncRNA MAGI2-As3 Suppresses the Proliferation and Invasion of cervical cancer by Sponging MiR-15b.
Chai Y; Wang L; Qu Y; Hu Z
J Healthc Eng; 2022; 2022():9707206. PubMed ID: 35126958
[TBL] [Abstract] [Full Text] [Related]
2. Integrated bioinformatic analysis of miR-15a/16-1 cluster network in cervical cancer.
S S; Shukla V; Khan GN; Eswaran S; Adiga D; Kabekkodu SP
Reprod Biol; 2021 Mar; 21(1):100482. PubMed ID: 33548740
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Zhang C; Ren X; Zhang W; He L; Qi L; Chen R; Tu C; Li Z
Bioengineered; 2020 Dec; 11(1):1112-1123. PubMed ID: 33124951
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of laparoscopic and abdominal radical hysterectomy for early stage cervical cancer: oncologic outcomes based on tumor diameter.
He J; Hao M; Liu P; Liu Z; Lang J; Bin X; Chen C
Int J Gynecol Cancer; 2020 Sep; 30(9):1308-1316. PubMed ID: 32699022
[TBL] [Abstract] [Full Text] [Related]
5. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery.
Bean LM; Ward KK; Plaxe SC; McHale MT
Am J Obstet Gynecol; 2017 Sep; 217(3):332.e1-332.e6. PubMed ID: 28522318
[TBL] [Abstract] [Full Text] [Related]
6. Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass.
Shoji T; Takatori E; Furutake Y; Takada A; Nagasawa T; Omi H; Kagabu M; Honda T; Miura F; Takeuchi S; Kumagai S; Yoshizaki A; Sato A; Sugiyama T
Int J Clin Oncol; 2016 Dec; 21(6):1120-1127. PubMed ID: 27342833
[TBL] [Abstract] [Full Text] [Related]
7. Serum YKL-40 as a marker for cervical adenocarcinoma.
Mitsuhashi A; Matsui H; Usui H; Nagai Y; Tate S; Unno Y; Hirashiki K; Seki K; Shozu M
Ann Oncol; 2009 Jan; 20(1):71-7. PubMed ID: 18723551
[TBL] [Abstract] [Full Text] [Related]
